Norway Archives - MEDIC NEST

NorwayNorwegian Cancer Precision Medicine Implementation Consortium

January 27, 2023by pcdata

Type: Cluster Project page: Access page Country: Norway Synopsis: ONNECT is a public-private consortium driving the implementation of precision cancer medicine by jointly addressing key obstacles and piloting novel solutions to transform the current practice. The consortium is coordinated by Oslo Cancer Cluster. CONNECT gathers all Norwegian university hospitals, pharmaceutical and technology companies.

NorwayOslo Cancer Cluster

January 27, 2023by pcdata

Type: Cluster Project page: Access page Country: Norway Synopsis: Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatment. Our member base comprises university hospitals, research centers, patient organizations, start-ups and biotech companies, global pharma and technology...

Belgium Denmark France Germany Hungary Netherlands Norway Switzerland UKMICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

July 19, 2022by pcdata

Dates: 01/01/2019 31/03/2025 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF) Keywords: liver cihrrosis; biomarker; clinical trial; ACLF; acute-on-chronic liver failure; OMICs; hepatology;...

Denmark France Hungary Latvia Norway Serbia Sweden Turkey UKFinding Endometriosis using Machine Learning

July 19, 2022by pcdata

Dates: 01/01/2021 31/12/2024 Topic: Tool Project type: Preclinic Medical Device Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.4.2. – Individual awareness and empowerment for self-management of health Participating agents: AARHUS UNIVERSITET Keywords: software; surgery; machine learning; endometriosis; uterus; app; OMICs; patient care Countries: Denmark; Hungary; UK; France; Latvia;...

France Greece Ireland Italy Netherlands Norway Spain Sweden Switzerland UK USANEw Clinical Endpoints in primary Sjögrens Syndrome: an Interventional Trial based on stratifYing patients

July 19, 2022by pcdata

Dates: 01/01/2019 31/12/2024 Topic: Biomarkers identification Project type: Clinic Preclinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: Countries: France; UK; Sweden; Netherlands; Spain; Greece; Ireland; Norway;...

Belgium France Italy Norway Spain USASimulation of Cardiac Devices & Drugs for in-silico Testing and Certification

July 19, 2022by pcdata

Dates: 01/01/2021 31/12/2024 Topic: Tool AI/Big Data Project type: Medical Device Project target: Cardiovascular disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5.3. – Using in-silico medicine for improving disease management and prediction Participating agents: INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE Keywords: AI; Big data; Cardiovascular; device; platform; model...

Belgium Croatia Denmark France Germany Ireland Italy Netherlands Norway Poland Portugal Spain Sweden Switzerland UKIdentification of the Molecular Mechanisms of non-response to Treatments; Relapses and Remission in Autoimmune; Inflammatory; and Allergic Conditions

July 19, 2022by pcdata

Dates: 01/09/2019 31/08/2026 Topic: Tool AI/Big Data Biomarkers identification Project type: Preclinic Clinic Guidelines Project target: Autoimmune disease Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD Keywords: systemic lupus erythematosus; rheumatoid arthritis; multiple sclerosis; asthma;...